News
04-14-2011, 09:10 PM
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced the completion of its previously announced acquisition of Apthera, Inc.
More... (http://www.news-medical.net/news/20110415/RXi-Pharmaceuticals-acquires-Apthera.aspx)
More... (http://www.news-medical.net/news/20110415/RXi-Pharmaceuticals-acquires-Apthera.aspx)